In a patient with diabetes, what is the cause and appropriate management of brown discoloration between the toes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Brown Discoloration Between Toes in Diabetic Foot

Brown discoloration between the toes in a diabetic patient most commonly represents either fungal infection (onychomycosis/tinea pedis with secondary skin changes), necrotic tissue from early dry gangrene, or chronic maceration with secondary bacterial colonization—immediate examination is required to differentiate these conditions and prevent progression to ulceration or infection.

Differential Diagnosis and Assessment

The brown discoloration requires urgent evaluation to determine the underlying cause:

Most Likely Causes:

  • Fungal infection with secondary skin changes - Common in diabetic patients with chronic moisture between toes
  • Early dry gangrene - Tissue necrosis from chronic ischemia causing brown/black discoloration
  • Chronic maceration with bacterial colonization - Can appear brown from tissue breakdown
  • Pre-ulcerative lesion - Requires immediate intervention per IWGDF guidelines

Critical Initial Assessment:

Perform comprehensive foot examination immediately 1:

  • Assess for loss of protective sensation using 10-g monofilament testing 2
  • Palpate pedal pulses to evaluate for peripheral artery disease 2, 1
  • Examine for tissue necrosis, moisture, odor, and skin integrity
  • Check for warmth, erythema, or signs of infection
  • Assess for foot deformities and limited joint mobility 1

Management Algorithm

If Fungal Infection (Most Common):

Treat aggressively as fungal infections in diabetic patients can lead to serious foot complications 1, 3:

  1. Topical antifungal therapy for mild cases
  2. Oral antifungal agents for moderate-to-severe cases, considering drug-drug interactions in diabetic patients 3
  3. Meticulous foot hygiene:
    • Wash feet daily with careful drying between toes 1
    • Apply emollients to dry skin (but not between toes if macerated)
    • Keep interdigital spaces dry

If Dry Gangrene Suspected:

Do not wait for autoamputation—early surgical intervention improves quality of life and prevents worse outcomes 4:

  • Dry gangrene appears as numb, dry, wrinkled, dead tissue 4
  • Conservative management with autoamputation leads to worse clinical outcomes in most cases 4
  • Refer immediately to vascular surgery for revascularization assessment
  • Consider early surgical amputation rather than prolonged conservative management 4

If Pre-ulcerative Lesion or Maceration:

Provide immediate treatment to prevent ulcer formation 1:

  1. Debride excess callus or necrotic tissue if present
  2. Offload pressure with appropriate footwear
  3. Address moisture - ensure proper drying between toes
  4. Monitor daily for progression to ulceration

Risk Stratification and Follow-up

Based on IWGDF 2023 guidelines 1:

  • If loss of protective sensation or PAD present: Patient is at minimum IWGDF risk 1
  • With foot deformity or pre-ulcerative lesion: IWGDF risk 2 (requires evaluation every 3-6 months)
  • With history of ulceration: IWGDF risk 3 (requires evaluation every 1-3 months)

Critical Patient Education

Educate the patient immediately on 1:

  • Daily foot inspection - examine between toes daily for changes
  • Never walk barefoot - not indoors or outdoors, even in socks alone
  • Proper foot hygiene - wash daily, dry carefully between toes
  • Immediate reporting - contact healthcare provider immediately if any lesion develops
  • Appropriate footwear - well-fitted shoes that accommodate foot shape 1

Common Pitfalls to Avoid

  1. Assuming brown discoloration is "just fungus" without ruling out ischemia or necrosis
  2. Waiting for autoamputation in dry gangrene cases—this worsens outcomes 4
  3. Inadequate drying between toes after washing—creates environment for fungal/bacterial growth
  4. Delaying vascular assessment when pulses are diminished or absent
  5. Failing to assess for neuropathy—patients may not feel pain from developing ulcers 2

When to Refer Immediately

  • Any tissue necrosis or suspected gangrene
  • Absent pedal pulses suggesting significant PAD
  • Signs of infection (warmth, erythema, purulent drainage)
  • Failure to improve with initial management within 1-2 weeks
  • Development of ulceration

The key principle: any foot abnormality in a diabetic patient requires prompt evaluation and aggressive management to prevent progression to ulceration, infection, and potential amputation.

References

Related Questions

How should a 79-year-old patient with diabetes who has had nocturia and increased thirst for the past month be evaluated and managed?
In a 73-year-old male smoker with diabetes who experiences constrictive retrosternal chest pain on minimal exertion that resolves after two minutes of rest, which diagnostic test is most appropriate to investigate the pain?
What discharge plan should be recommended for a postpartum woman, two days after delivery, with type 2 diabetes on insulin glargine (Lantus) 9 U daily without carbohydrate coverage, who is breastfeeding and currently has hyperglycemia?
In a 71-year-old female with unintentional weight loss of 20 lb over 6 months, who is a cigarette smoker and has pre‑existing diabetes, what differential diagnoses should be considered?
In a 74-year-old diabetic man presenting with acute scrotal and perineal pain, dusky violaceous skin changes, and crepitus, what is the most appropriate immediate management?
What is the appropriate duration of antibiotic therapy for a patient with ruptured appendicitis without source control who has a National Early Warning Score 2 (NEWS2) of 0?
Can an adult who has tolerated lower doses of venlafaxine and has no severe hepatic impairment, uncontrolled hypertension, or recent MAOI use be started on venlafaxine extended‑release 225 mg daily?
Should a PET/CT scan be performed for a 7 mm pulmonary nodule that increased from 5 mm to 7 mm over one year?
How should methylxanthine therapy be initiated and managed in adults with persistent asthma, including dosing, serum concentration monitoring, alternatives such as doxofylline, and criteria for switching to other add‑on treatments?
How should I briefly explain to a new patient why we cannot continue a daily dose of 100 mg methylphenidate (Ritalin) as it is unsafe, while refilling clonazepam 3 mg daily?
In a patient with exertional chest pain and dyspnea, prior cardiac intervention, whose Tc-99m sestamibi stress‑rest SPECT shows uniform left‑ventricular perfusion, mild fixed apical thinning (scar), no reversible defect, and normal wall motion with ejection fraction >60 %, what does this indicate and how should it be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.